Drug Landscape ›
Pred Forte ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 1,688
Most-reported reactions
Eye Pain — 312 reports (18.48%) Off Label Use — 196 reports (11.61%) Drug Ineffective — 192 reports (11.37%) Vision Blurred — 182 reports (10.78%) Eye Irritation — 156 reports (9.24%) Headache — 150 reports (8.89%) Ocular Hyperaemia — 140 reports (8.29%) Fatigue — 129 reports (7.64%) Cataract — 121 reports (7.17%) Nausea — 110 reports (6.52%)
Source database →
Pred Forte in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Pred Forte approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Pred Forte in United States?
University of Colorado, Denver is the originator. The local marketing authorisation holder may differ — check the official source linked above.